Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.030
+0.040 (2.01%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Pyxis Oncology Employees
Pyxis Oncology had 56 employees as of December 31, 2025. The number of employees increased by 12 or 27.27% compared to the previous year. That makes Pyxis Oncology the 34,459th largest employer in the world and 4,590th in the United States.
Employees
56
Change (1Y)
12
Growth (1Y)
27.27%
Revenue / Employee
$197,107
Profits / Employee
-$1,584,411
Market Cap
242.50M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 56 | 12 | 27.27% |
| Dec 31, 2024 | 44 | -6 | -12.00% |
| Sep 30, 2024 | 54 | -13 | -19.40% |
| Jun 30, 2024 | 55 | -17 | -23.61% |
| Mar 31, 2024 | 51 | -22 | -30.14% |
| Dec 31, 2023 | 50 | -25 | -33.33% |
| Sep 30, 2023 | 67 | -6 | -8.22% |
| Jun 30, 2023 | 72 | 5 | 7.46% |
| Mar 31, 2023 | 73 | 9 | 14.06% |
| Dec 31, 2022 | 75 | 19 | 33.93% |
| Sep 30, 2022 | 73 | 28 | 62.22% |
| Jun 30, 2022 | 67 | 29 | 76.32% |
| Mar 31, 2022 | 64 | 26 | 68.42% |
| Dec 31, 2021 | 56 | - | - |
| Sep 30, 2021 | 45 | - | - |
| Jun 30, 2021 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sutro Biopharma | 128 |
| Nautilus Biotechnology | 127 |
| Zentalis Pharmaceuticals | 106 |
| Century Therapeutics | 78 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 57 |
| Camp4 Therapeutics | 48 |
| Vicore Pharma Holding AB | 46 |
PYXS News
- 1 day ago - Pyxis Oncology Proxy statement: Proxy filing - Filings
- 8 days ago - Pyxis Oncology announces closing of up to $282.6M public offering - TheFly
- 8 days ago - Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering - GlobeNewsWire
- 10 days ago - Pyxis Oncology 36M share Spot Secondary priced at $2.90 - TheFly
- 10 days ago - Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering - GlobeNewsWire
- 11 days ago - Pyxis Oncology announces common stock offering, no amount given - TheFly
- 11 days ago - Pyxis Oncology Announces Proposed Public Offering - GlobeNewsWire
- 4 weeks ago - Pyxis Oncology price target raised to $8 from $7 at H.C. Wainwright - TheFly